索引超出了数组界限。
[1] Matsuura H, Ichida F, Saji T, et al. Clinical features of acute and fulminant myocarditis in children—2nd nationwide survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery[J]. Circ J, 2016, 80(11):2362-2368.
[2] Amraotkar AR, Pachika A, Grubb KJ, et al. Rapid extracorporeal membrane oxygenation overcomes fulminant myocarditis induced by 5-fluorouracil[J]. Tex Heart Inst J, 2016, 43(2):178-182.
[3] Lorusso R, Centofanti P, Gelsomino S, et al. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience[J]. Ann Thorac Surg, 2016, 101(3):919-926.
[4] Xiong H, Xia B, Zhu J, et al. Clinical outcomes in pediatric patients hospitalized with fulminant myocarditis requiring extracorporeal membrane oxygenation: a meta-analysis[J]. Pediatr Cardiol, 2017, 38(2):209-214.
[5] Bjelakovic B, Vukomanovic V, Jovic M. Fulminant myocarditis in children successfully treated with high dose of methyl-prednisolone[J]. Indian J Pediatr, 2016, 83(3):268-269.
[6] Tiruvoipati R, Botha J, Peek G. Effectiveness of extracorporeal membrane oxygenation when conventional ventilation fails: valuable option or vague remedy?[J]. J Crit Care, 2012, 27(2):192-198.
[7] Brogan TV, Thiagarajan RR, Rycus PT, et al. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database[J]. Intensive Care Med, 2009, 35(12):2105-2114.
[8] 叶莉芬, 范勇, 张晨美, 等. 体外膜肺氧合抢救儿童急性暴发性心肌炎12例[J]. 中华儿科杂志, 2016, 54(11):843-846.